Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells

Park,Ki-Woong; Kundu,Juthika; Chae,In-Gyeong; Kim,Do-Hee; Yu,Mi-Hee; Kundu,Joydeb Kumar; Chun,Kyung-Soo

doi:10.3892/ijo.2014.2281

Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells

Authors:
- Ki-Woong Park
- Juthika Kundu
- In-Gyeong Chae
- Do-Hee Kim
- Mi-Hee Yu
- Joydeb Kumar Kundu
- Kyung-Soo Chun
View Affiliations

Affiliations: College of Pharmacy, Keimyung University, Daegu 704-701, Republic of Korea, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea, Department of Food Science and Technology, Keimyung University, Daegu 704-701, Republic of Korea
Published online on: January 27, 2014 https://doi.org/10.3892/ijo.2014.2281
Pages: 1309-1315

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Carnosol, an active constituent of rosemary, has been reported to possess anti-inflammatory and anticancer activities. However, the molecular mechanisms underlying the anticancer effects of carnosol remain poorly understood. In the present study, we found that carnosol significantly reduced the viability of human colon cancer (HCT116) cells in a concentration- and time-dependent manner. Treatment of cells with carnosol induced apoptosis, which was associated with activation of caspase-9 and -3 and the cleavage of poly-(ADP-ribose) polymerase (PARP). Incubation with carnosol elevated the expression of Bax and inhibited the levels of Bcl-2 and Bcl-xl. Carnosol induced expression of p53 and inhibited that of murine-double minute-2 (Mdm2). Moreover, carnosol generated reactive oxygen species (ROS), and pretreatment with N-acetyl cysteine abrogated carnosol-induced cleavage of caspase-3 and PARP. The constitutive phosphorylation, the DNA binding and reporter gene activity of signal transducer and activator of transcription-3 (STAT3) was diminished by treatment with carnosol. To further elucidate the molecular mechanisms of STAT3 inactivation, we found that carnosol attenuated the phosphorylation of Janus-activated kinase-2 (Jak2) and Src kinase. Pharmacological inhibition of Jak2 and Src inhibited STAT3 phosphorylation. Furthermore, carnosol attenuated the expression of STAT3 target gene products, such as survivin, cyclin-D1, -D2, and -D3. Taken together, our study provides the first report that carnosol induced apoptosis in HCT116 cells via generation of ROS, induction of p53, activation of caspases and inhibition of STAT3 signaling pathway.

View Figures

View References

1.	Jemal A, Center MM, DeSantis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
3.	Merika E, Saif MW, Katz A, Syrigos K and Morse M: Review. Colon cancer vaccines: an update. In Vivo. 24:607–628. 2010.PubMed/NCBI
4.	Chung MY, Lim TG and Lee KW: Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol. 19:984–993. 2013. View Article : Google Scholar : PubMed/NCBI
5.	Moran AE, Carothers AM, Weyant MJ, Redston M and Bertagnolli MM: Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/ Min/+ (Min/+) mouse. Cancer Res. 65:1097–1104. 2005.PubMed/NCBI
6.	Cheng AC, Lee MF, Tsai ML, et al: Rosmanol potently induces apoptosis through both the mitochondrial apoptotic pathway and death receptor pathway in human colon adenocarcinoma COLO 205 cells. Food Chem Toxicol. 49:485–493. 2011. View Article : Google Scholar
7.	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
8.	Neergheen VS, Bahorun T, Taylor EW, Jen LS and Aruoma OI: Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology. 278:229–241. 2010. View Article : Google Scholar
9.	Burz C, Berindan-Neagoe I, Balacescu O and Irimie A: Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol. 48:811–821. 2009. View Article : Google Scholar : PubMed/NCBI
10.	Martin SJ and Green DR: Protease activation during apoptosis: death by a thousand cuts? Cell. 82:349–352. 1995. View Article : Google Scholar : PubMed/NCBI
11.	Aggarwal BB, Takada Y and Oommen OV: From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs. 13:1327–1338. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Johnston PA and Grandis JR: STAT3 signaling: anticancer strategies and challenges. Mol Interv. 11:18–26. 2011. View Article : Google Scholar : PubMed/NCBI
13.	Masuda M, Suzui M, Yasumatu R, et al: Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 62:3351–3355. 2002.
14.	Lau GK and Ye D: STAT3 implicated in the development of colon cancer: a step closer for targeted therapy? Gastroenterology. 139:353–355. 2010. View Article : Google Scholar : PubMed/NCBI
15.	Lin L, Liu A, Peng Z, et al: STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res. 71:7226–7237. 2011. View Article : Google Scholar : PubMed/NCBI
16.	Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL and Wolff RK: JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog. 52:155–166. 2013. View Article : Google Scholar : PubMed/NCBI
17.	Laird AD, Li G, Moss KG, et al: Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells. Mol Cancer Ther. 2:461–469. 2003.
18.	Kundu J, Wahab SM, Kundu JK, et al: Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting beta-catenin signaling. Int J Oncol. 41:839–848. 2012.PubMed/NCBI
19.	Kundu JK, Shin YK, Kim SH and Surh YJ: Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis. 27:1465–1474. 2006. View Article : Google Scholar : PubMed/NCBI
20.	Johnson JJ: Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett. 305:1–7. 2011. View Article : Google Scholar : PubMed/NCBI
21.	Dorrie J, Sapala K and Zunino SJ: Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett. 170:33–39. 2001. View Article : Google Scholar : PubMed/NCBI
22.	Johnson JJ, Syed DN, Heren CR, Suh Y, Adhami VM and Mukhtar H: Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5′-AMP-activated protein kinase (AMPK) pathway. Pharm Res. 25:2125–2134. 2008.PubMed/NCBI
23.	Cherbonnel-Lasserre C and Dosanjh MK: Suppression of apoptosis by overexpression of Bcl-2 or Bcl-xL promotes survival and mutagenesis after oxidative damage. Biochimie. 79:613–617. 1997. View Article : Google Scholar
24.	Zhu S, Li T, Tan J, et al: Bax is essential for death receptor-mediated apoptosis in human colon cancer cells. Cancer Biother Radiopharm. 27:577–581. 2012. View Article : Google Scholar : PubMed/NCBI
25.	Valassiadou KE, Stefanaki K, Tzardi M, et al: Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas. Anticancer Res. 17:2571–2576. 1997.PubMed/NCBI
26.	Bonnotte B, Favre N, Moutet M, et al: Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J Immunol. 161:1433–1438. 1998.PubMed/NCBI
27.	Shaw P, Bovey R, Tardy S, Sahli R, Sordat B and Costa J: Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA. 89:4495–4499. 1992. View Article : Google Scholar : PubMed/NCBI
28.	Kim DH, Kundu JK and Surh YJ: Redox modulation of p53: mechanisms and functional significance. Mol Carcinog. 50:222–234. 2011. View Article : Google Scholar : PubMed/NCBI
29.	Rigatti MJ, Verma R, Belinsky GS, Rosenberg DW and Giardina C: Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells. Mol Carcinog. 51:363–378. 2012. View Article : Google Scholar : PubMed/NCBI
30.	Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:293–299. 1995. View Article : Google Scholar : PubMed/NCBI
31.	Miyashita T, Krajewski S, Krajewska M, et al: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1799–1805. 1994.PubMed/NCBI
32.	Lotem J, Peled-Kamar M, Groner Y and Sachs L: Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA. 93:9166–9171. 1996. View Article : Google Scholar : PubMed/NCBI
33.	Corvinus FM, Orth C, Moriggl R, et al: Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia. 7:545–555. 2005. View Article : Google Scholar : PubMed/NCBI
34.	Lin Q, Lai R, Chirieac LR, et al: Constitutive activation of JAK3/ STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol. 167:969–980. 2005. View Article : Google Scholar : PubMed/NCBI
35.	Kanda N, Seno H, Konda Y, et al: STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene. 23:4921–4929. 2004. View Article : Google Scholar : PubMed/NCBI
36.	Asanuma K, Tsuji N, Endoh T, Yagihashi A and Watanabe N: Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J Immunol. 172:3922–3929. 2004. View Article : Google Scholar